|
Federal
Register Notices > Notices
of Registration - 2008 >
United
States Pharmacopeial Convention
FR Doc E8-17965[Federal Register: August 6, 2008 (Volume 73,
Number 152)] [Notices] [Page 45781-45782] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-88]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated February 12, 2008 and published in the
Federal Register on February 21, 2008, (73 FR 9591), United
States Pharmacopeial Convention, 12601 Twinbrook Parkway,
Rockville, Maryland 20852, made application to the Drug
Enforcement Administration (DEA) to be registered as an importer
of the basic classes of controlled substances listed in
schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
Codeine-n-oxide (9053)
|
I
|
|
Heroin (9200)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Phenmetrazine (1631)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Glutethimide (2550)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Alphaprodine (9010)
|
II
|
|
Anileridine (9020)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Diphenoxylate (9170)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to import reference standards for sale to
researchers and analytical labs.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a) and
determined that the registration of United States Pharmacopeial
Convention to import the basic classes of controlled substances
is consistent with the public interest and with United States
obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has
investigated United States Pharmacopeial Convention to ensure
that the company's registration is consistent with the public
interest. The investigation has included inspection and testing
of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of
the company's background and history. Therefore, pursuant to 21
U.S.C. 952(a) and 958(a), and in accordance with
21 CFR
1301.34,
the above named company is granted registration as an importer
of the basic classes of controlled substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration.
[FR Doc. E8-17965 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
